4//SEC Filing
Burkavage Brian 4
Accession 0000905148-24-000967
CIK 0001865494other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:22 PM ET
Size
5.3 KB
Accession
0000905148-24-000967
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Burkavage Brian
Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-03-15+50,000→ 50,000 totalExercise: $1.65Exp: 2034-03-15→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001865633
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:22 PM ET
- Size
- 5.3 KB